Please login to the form below

Not currently logged in
Email:
Password:

New CEO for Grayling Germany

Frank Schönrock joins from Grünenthal
grayling Frank Schonrock

Frank Schönrock has left his role at pharma company Grünenthal to join the med comms agency Grayling Germany as CEO.

Schönrock joined Grünenthal in 2011 as VP of corporate communications before moving onto a global external communications role in his last year at the company. He was also a member of Grünenthal's global group leadership committee.

He now heads the German division of global comms network Grayling, overseeing a team of 40 consultants in Frankfurt, Düsseldorf and Hamburg.

Schönrock has previous agency experience having spent 12 year at Edelman Germany in several management positions, including co-heading the firms' office in Frankfurt.

“Frank is an exceptional talent and we are very proud to have him on board,” said Jan Simunek, Grayling's regional director for the DACH region, Central & Eastern Europe, Russia and CIS

“His background in healthcare, financial services, issues & crisis management and litigation PR will be particularly valuable as we look to grow the firm in Germany over the months and years to come.”

6th November 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics